Laurel, MD, United States of America

Hisataka Kobayashi

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 2.6

ph-index = 5

Forward Citations = 64(Granted Patents)


Location History:

  • Nishinomiya, JP (2005)
  • Laurel, MD (US) (2013 - 2023)

Company Filing History:


Years Active: 2005-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Hisataka Kobayashi

Introduction

Hisataka Kobayashi is a distinguished inventor based in Laurel, MD, who has made significant contributions to the fields of medicine and immunotherapy. With a substantial portfolio of 13 patents, Kobayashi has focused his research on advanced treatments such as near-infrared photoimmunotherapy.

Latest Patents

Among his latest inventions are groundbreaking patents related to photosensitizing antibody-fluorophore conjugates. These compositions and methods aim to kill cells either in vitro or in vivo. The innovative approach involves utilizing an antibody-IR700 molecule that specifically binds to tumor-specific antigens present on tumor cells. By irradiating the treated cells with a specific wavelength, Kobayashi's method effectively destroys unwanted cells. Additionally, he has developed wearable devices integrated with Near-Infrared (NIR) LEDs, which can be used with his treatment methods. Another significant patent focuses on a method and apparatus for testing the efficiency of near-infrared photoimmunotherapy. This process includes injecting an antibody photosensitizer conjugate into patients, applying radiation, and measuring the therapeutic outcome through liquid chromatography-mass spectrometry.

Career Highlights

Kobayashi has notably worked with reputable organizations, including the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services and Shimadzu Corporation. His work has contributed to the advancement of medical technologies aimed at improving cancer treatment options.

Collaborations

Throughout his career, Kobayashi has collaborated with esteemed colleagues, including Peter Choyke and Martin John Schnermann. These partnerships have played a crucial role in enhancing the efficacy of his inventions and expanding their potential applications within the medical field.

Conclusion

Hisataka Kobayashi's innovative contributions have paved the way for new methodologies in cancer treatment through photoimmunotherapy. His dedication to advancing medical technology is evident in his numerous patents and collaborations with leading experts. As the field of medical research continues to evolve, Kobayashi's work holds promise for the future of patient care and therapeutic effectiveness.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…